LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 18.98 | 27.76 | 733 | 941 | 0.7788 | 0.9040 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 18.98 | 27.76 | 947 | 941 | 1.0062 | 1.0024 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 20.68 | 27.76 | 887 | 1119 | 0.7927 | 0.9147 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 20.68 | 27.76 | 918 | 1119 | 0.8204 | 0.9271 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 20.68 | 27.76 | 877 | 1119 | 0.7837 | 0.9107 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 20.68 | 27.76 | 1015 | 1119 | 0.9071 | 0.9638 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 22.39 | 27.76 | 883 | 1305 | 0.6763 | 0.8640 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 22.39 | 27.76 | 904 | 1305 | 0.6923 | 0.8719 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 22.39 | 27.76 | 844 | 1305 | 0.6464 | 0.8489 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 22.39 | 27.76 | 931 | 1305 | 0.7130 | 0.8819 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 24.09 | 27.76 | 885 | 1461 | 0.6055 | 0.8320 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 24.09 | 27.76 | 901 | 1461 | 0.6164 | 0.8378 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 24.09 | 27.76 | 880 | 1461 | 0.6021 | 0.8302 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 24.09 | 27.76 | 949 | 1461 | 0.6493 | 0.8545 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 25.79 | 27.76 | 853 | 1605 | 0.5314 | 0.7953 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 25.79 | 27.76 | 868 | 1605 | 0.5408 | 0.8006 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 25.79 | 27.76 | 960 | 1605 | 0.5981 | 0.8319 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 25.79 | 27.76 | 1023 | 1605 | 0.6373 | 0.8519 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 27.49 | 27.76 | 883 | 1723 | 0.5124 | 0.7876 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 27.49 | 27.76 | 900 | 1723 | 0.5223 | 0.7934 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 27.49 | 27.76 | 937 | 1723 | 0.5438 | 0.8055 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 27.49 | 27.76 | 983 | 1723 | 0.5705 | 0.8201 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 29.19 | 27.76 | 911 | 1863 | 0.4890 | 0.7776 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 29.19 | 27.76 | 922 | 1863 | 0.4949 | 0.7811 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 29.19 | 27.76 | 909 | 1863 | 0.4879 | 0.7769 | MN20160318_Q01 | H10 |